| 000 | 01856 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516053830.0 | ||
| 264 | 0 | _c20120316 | |
| 008 | 201203s 0 0 eng d | ||
| 022 | _a1460-2393 | ||
| 024 | 7 |
_a10.1093/qjmed/hcr138 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTesta, L | |
| 245 | 0 | 0 |
_aMulti-Link Vision stent vs. first-generation drug-eluting stents: systematic review and meta-analysis. _h[electronic resource] |
| 260 |
_bQJM : monthly journal of the Association of Physicians _cDec 2011 |
||
| 300 |
_a1025-34 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review; Systematic Review | ||
| 650 | 0 | 4 | _aChromium Alloys |
| 650 | 0 | 4 |
_aCoronary Stenosis _xsurgery |
| 650 | 0 | 4 |
_aDrug-Eluting Stents _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMyocardial Infarction _xepidemiology |
| 650 | 0 | 4 |
_aMyocardial Revascularization _xstatistics & numerical data |
| 650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aRegistries |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aSirolimus _xadministration & dosage |
| 650 | 0 | 4 |
_aStents _xadverse effects |
| 650 | 0 | 4 |
_aThrombosis _xepidemiology |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTubulin Modulators _xadministration & dosage |
| 700 | 1 | _aLatini, R A | |
| 700 | 1 | _aPizzocri, S | |
| 700 | 1 | _aLanotte, S | |
| 700 | 1 | _aAgnifili, M | |
| 700 | 1 | _aLaudisa, M L | |
| 700 | 1 | _aBrambilla, N | |
| 700 | 1 | _aBedogni, F | |
| 773 | 0 |
_tQJM : monthly journal of the Association of Physicians _gvol. 104 _gno. 12 _gp. 1025-34 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/qjmed/hcr138 _zAvailable from publisher's website |
| 999 |
_c21137163 _d21137163 |
||